These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 23508544)
1. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544 [TBL] [Abstract][Full Text] [Related]
2. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Picard W; Bazin F; Clouzeau B; Bui HN; Soulat M; Guilhon E; Vargas F; Hilbert G; Bouchet S; Gruson D; Moore N; Boyer A Antimicrob Agents Chemother; 2014 Dec; 58(12):7468-74. PubMed ID: 25288085 [TBL] [Abstract][Full Text] [Related]
3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Croes S; Koop AH; van Gils SA; Neef C Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306 [TBL] [Abstract][Full Text] [Related]
6. Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring. Slaughter RL; Cappelletty DM Pharmacoeconomics; 1998 Oct; 14(4):385-94. PubMed ID: 10344906 [TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides use in patients over 75 years old. Fraisse T; Gras Aygon C; Paccalin M; Vitrat V; De Wazieres B; Baudoux V; Lechiche C; Vicens A; Sotto A; Pagani L; Gaillat J; Forestier E; Gavazzi G Age Ageing; 2014 Sep; 43(5):676-81. PubMed ID: 24590569 [TBL] [Abstract][Full Text] [Related]
9. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Barclay ML; Kirkpatrick CM; Begg EJ Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis. Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248 [TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity. Pai MP; Rodvold KA Diagn Microbiol Infect Dis; 2014 Feb; 78(2):178-87. PubMed ID: 24268292 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological considerations for the proper clinical use of aminoglycosides. Pagkalis S; Mantadakis E; Mavros MN; Ammari C; Falagas ME Drugs; 2011 Dec; 71(17):2277-94. PubMed ID: 22085385 [TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients. Malacarne P; Bergamasco S; Donadio C Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027 [TBL] [Abstract][Full Text] [Related]
15. Once-daily aminoglycoside dosing: An update on current literature. Stankowicz MS; Ibrahim J; Brown DL Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292 [TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside nephrotoxicity: do time and frequency of administration matter? Beauchamp D; Labrecque G Curr Opin Crit Care; 2001 Dec; 7(6):401-8. PubMed ID: 11805542 [TBL] [Abstract][Full Text] [Related]
18. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients. Schentag JJ; Cerra FB; Plaut ME Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453 [TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Koo J; Tight R; Rajkumar V; Hawa Z Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358 [TBL] [Abstract][Full Text] [Related]
20. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]